Skip to main content
Abnova (Taiwan) Corporation logo

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Filings indexed 1,474 across all filing types
Latest filing 2017-07-03 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議委任第三屆薪資報酬委員會委員
Regulatory Filings
2017-07-03 Chinese
公告本公司完成審計委員會之設置,並選任審計委員會召集人
Regulatory Filings
2017-06-23 Chinese
公告本公司第二屆薪資報酬委員會委員解任
Regulatory Filings
2017-06-23 Chinese
本公司董事會推舉Wilber Huang先生續任董事長
Regulatory Filings
2017-06-23 Chinese
公告本公司106年股東常會決議通過解除新任董事及其代表人 競業禁止事宜
Regulatory Filings
2017-06-23 Chinese
公告本公司106年股東常會全面改選董事當選名單
Regulatory Filings
2017-06-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.